solar Pharma issues To Linger On for two-three Quarters: Jefferies
Mumbai: Headwinds plaguing solar Pharmaceutical, India's biggest drug maker, will continue for the nexttwo-3 quarters because of pricing pressures and ...
Mumbai: Headwinds plaguing solar Pharmaceutical, India's biggest drug maker, will continue for the nexttwo-3 quarters because of pricing pressures and ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.